Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2018-03-30 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
180330 - Notification de transparence press release The Capital GC.pdf
Major Shareholding Notification Classification · 99% confidence The document is a 'Déclaration de transparence' (Transparency Declaration) issued by UCB SA, announcing that The Capital Group Companies Inc. has notified them of a decrease in their shareholding, crossing below the 3% threshold. This type of filing specifically concerns changes in significant share ownership levels by an entity or individual, which directly corresponds to the definition of Major Shareholding Notification (MRQ). The text details the previous holding, the new holding (2.91%), the date of crossing the threshold (March 27, 2018), and the legal basis (law of May 2, 2007, regarding the disclosure of major shareholdings). This is a classic example of an insider/major shareholder transaction disclosure.
2018-03-30 French
180330 - Transparantieverklaring persbericht The Capital Group Companies.pdf
Director's Dealing Classification · 98% confidence The document is titled "Transparantieverklaring" (Transparency Declaration) and explicitly states it is a notification received based on the law regarding the disclosure of major shareholdings ("openbaarmaking van belangrijke deelnemingen"). It details a change in the shareholding percentage of The Capital Group Companies Inc. in UCB NV, specifically noting that the holding dropped below the 3% threshold on March 27, 2018. This content directly corresponds to notifications about changes in significant share ownership levels, which matches the definition for Major Shareholding Notification (MRQ). Although it is a regulatory disclosure, MRQ is more specific than the general RNS category.
2018-03-30 Dutch
Special Board Report (art.604) ANG.pdf
Capital/Financing Update Classification · 92% confidence The document is explicitly titled a "SPECIAL REPORT BY THE BOARD OF DIRECTORS TO THE SHAREHOLDERS on the use and purpose of the authorized capital prepared in accordance with article 604 of the Belgian Companies Code". It discusses proposals related to renewing the Board's power to increase share capital, which directly relates to capital structure and shareholder rights concerning share issuance. This content is highly specific to corporate governance and capital management decisions presented to shareholders, often preceding or accompanying a general meeting vote. While it touches upon capital changes (SHA) and governance (CGR), its primary function as a formal report justifying a proposal for shareholder approval regarding capital authorization aligns best with documents related to shareholder meetings and corporate structure proposals. Since it is a detailed report justifying a proposal to be voted on at an Extraordinary General Shareholders' Meeting, and it deals with capital structure changes, it is most closely related to the context of shareholder voting and capital management. Given the options, it is a formal report detailing governance/capital structure proposals for shareholder consideration. It is not a standard 10-K, ER, or IR. It is a specific report related to capital authorization, which falls under the broader scope of corporate governance/shareholder matters. Since it is a detailed report justifying a proposal for shareholder approval regarding capital authorization, it is best classified as a document related to capital structure/financing proposals presented to shareholders, which is closest to 'Capital/Financing Update' (CAP) or a specific governance document. However, the core purpose is to justify the renewal of the authorized capital powers, which is a fundamental aspect of corporate governance and capital structure. Given the detailed nature and the reference to the Extraordinary General Shareholders' Meeting, it functions as a key document for that meeting. It is not a proxy statement (PSI) or a declaration of voting results (DVA). It is a formal report justifying a capital action. 'CAP' covers financing activities, and renewing authorized capital is a prerequisite for future financing. 'CGR' covers internal rules/board structure. This document is a specific report mandated by law (Art. 604 BCC) for a shareholder vote on capital powers. Given the options, 'CAP' (Capital/Financing Update) is a strong fit as it deals with the mechanism for future capital increases. Alternatively, since it is a formal report presented to shareholders regarding corporate structure/powers, it has governance elements. Given the focus on authorizing the Board to increase capital, 'CAP' is the most direct fit for the subject matter being reported on, even though it's structured as a special report. I will classify it as CAP as it is fundamentally about the mechanism for future capital changes.
2018-03-23 English
UCB SA Procuration Assemblée Générale 26 avril 2018 .pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is explicitly titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 26 AVRIL 2018" (Proxy for the General Shareholders' Meeting of April 26, 2018). It contains instructions for shareholders on how to appoint a proxy to vote on various resolutions, including the approval of annual accounts, remuneration reports, director re-elections, and long-term incentive plans. This material is designed to solicit shareholder votes and provide necessary information ahead of the meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it touches upon items typically found in an Annual Report (like approving 2017 accounts), the document's primary function is soliciting proxy votes for the AGM.
2018-03-23 French
Bijzonder verslag RVB (art.604) NDL.pdf
Capital/Financing Update Classification · 98% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR AAN DE AANDEELHOUDERS over het gebruik en de nagestreefde doeleinden van het toegestane kapitaal opgesteld overeenkomstig artikel 604 van het Wetboek van vennootschappen" (Special Report of the Board of Directors to the Shareholders concerning the use and intended purposes of the authorized capital drawn up in accordance with Article 604 of the Companies Code). This document explicitly discusses the renewal of the Board's authorization to increase capital, which is a core topic related to corporate financing and capital structure, presented to shareholders for approval at an Extraordinary General Meeting (EGM). This strongly aligns with the definition of a document related to Capital/Financing Update (CAP). While it is a report presented to shareholders, its primary focus is the authorization mechanism for capital changes, not a general annual report (10-K) or a simple dividend notice (DIV). It is a specific report detailing proposed changes to capital authority, making CAP the most appropriate fit over a general Regulatory Filing (RNS) or a Governance Report (CGR).
2018-03-23 Dutch
UCB SA-NV Proxy General Meeting 26 April 2018.pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is explicitly titled "PROXY FOR THE GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON 26 APRIL 2018". It contains instructions on how to appoint a proxy holder, voting instructions for various resolutions (including approval of annual accounts, remuneration report, director renewals, and capital authorization), and details about both Ordinary and Extraordinary General Meetings. This content is characteristic of materials sent to shareholders to solicit their votes and appoint representatives for a shareholder meeting, which falls under the definition of Proxy Solicitation & Information Statement.
2018-03-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.